Emma Zhao

Emma Zhao

Auto-generated profile, based on publicly available information

Emma Zhao

Faculty of Medicine and Health, University of Sydney , Western Avenue, Camperdown, NSW 2006

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 April 2024 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
YLYi-Ching Lee
Yi-Ching Lee
TBTimothy Brake
Timothy Brake
EZEmma Zhao
Emma Zhao
ADAlix Dumitrescu
Alix Dumitrescu
WLWei Lee
Wei Lee
AWAndy Yi-Yang Wang
Andy Yi-Yang Wang
Context: Pain is a common experience in people living with cancer. Concerns around opioid prescribing have seen a move toward a multi-modality management approach, which includes interventional pain procedures. Purpose: In this paper we discuss the interventional pain procedures used to treat cancer pain at two major tertiary centers in Australia. Methods and results: This expert review provides practical insights on cancer pain management from healthcare providers in different specialties. These insights can be used to guide the management of a wide range of cancer pain types. Conclusions: Furthermore, this review identifies the need for a systematic and comprehensive approach to the management of cancer pain that is broader than that of a single specialty. With recent advances in pain management procedures, an interdisciplinary approach is essential in order to provide an up to date, patient tailored approach to pain management. This review will help inform the development of a cancer pain intervention registry.

11 March 2024 in Heart, Lung and Circulation
Verified
Journal Article
Open access
EZEmma Zhao
Emma Zhao
NLNicole Lowres
Nicole Lowres
JBJacqueline Bloomfield
Jacqueline Bloomfield
JWJoseph Weddell
Joseph Weddell
GTGeoffrey Tofler
Geoffrey Tofler
RGRobyn Gallagher
Robyn Gallagher
Cognitive impairment (CI) is common in patients with acute coronary syndrome (ACS) but is often undetected and may affect recovery and secondary prevention uptake. Nurses play a crucial role providing care for patients with ACS and promoting secondary prevention. This study aimed to explore current nursing practices and barriers regarding CI screening in patients with ACS. Cardiac nurses were recruited from three metropolitan teaching hospitals and two professional associations in Australia and undertook a 38-question purpose-built survey. A total of 95 nurses participated (mean age 38±13 years; 78% [n=74] female): 69 were registered nurses, and 48% had received CI training. Only 16% of nurses in our sample reported that they regularly screen for CI, and 23% reported that they never screen; however, 59% believed screening should be part of everyday practice. Nurses mostly screened when ward policy required admission/daily cognitive screening (34%) or when they suspected cognitive problems or decline (39%). Nurses in acute settings (vs non-acute) were nine times more likely to screen when adjusting for confounders. The typically used screening instruments assessed delirium/confusion and dementia but not milder CI. Common barriers to screening included communication difficulties, patients too unstable/unwell, time constraints requiring clinical care prioritisation, and being unaware of patients' normal cognition status. Screening practices for CI in the context of ACS were found to be suboptimal, with only 16% of nurses in our sample reporting regularly screening. The most used methods focus on screening for delirium. Given current practice, many CI cases will be missed, especially mild CI, which will negatively affect secondary prevention efforts. Further research is required to identify appropriate methods to implement routine screening within the nursing clinical workflow and establish a suitable screening tool.

27 October 2021 in Journal of Cardiovascular Nursing
Verified
Journal Article
Closed access
EZEmma Mn Zhao
Emma Mn Zhao
NLNicole Lowres
Nicole Lowres
SNSharon L. Naismith
Sharon L. Naismith
GTGeoffrey Tofler
Geoffrey Tofler
ABAdrian Bauman
Adrian Bauman
RGRobyn PhD Gallagher
Robyn PhD Gallagher
Background: Cognitive impairment (CI) may contribute to difficulties in understanding and implementing secondary prevention behavior change after acute coronary syndrome (ACS), but the association is poorly understood. Objectives: The aim of this study was to explore the prevalence of CI in patients 4 weeks post ACS and the association with health literacy and secondary prevention. Methods: Patients with ACS who were free from visual deficits, auditory impairment, and dementia diagnoses were recruited and assessed 4 weeks post discharge for cognitive function (Montreal Cognitive Assessment and Hopkins Verbal Learning Test), health literacy (Newest Vital Sign), depression (Patient Health Questionnaire), physical activity (Fitbit Activity Tracker and Physical Activity Scale for the Elderly), and medication knowledge and adherence. Results: Participants (n = 45) had an average age of 65 ± 11 years, 82% were male, 64% were married/partnered, and 82% had high school education or higher. Overall CI was identified in 28.9% (n = 13/45) of the patients 4 weeks after discharge, which was composed of patients detected on both the Montreal Cognitive Assessment and Hopkins Verbal Learning Test (n = 3), patients detected on Montreal Cognitive Assessment alone (n = 6), and patients detected on Hopkins Verbal Learning Test alone (n = 4). Fewer patients with CI had adequate health literacy (61.4%) than patients with normal cognition (90.3%, P = .024). Significant correlations were found between Hopkins Verbal Learning Test scores and medication knowledge (0.4, P = .008) and adherence (0.33, P = .029). Conclusions: In this exploratory study, 30% of patients with ACS demonstrated CI at 4 weeks post discharge. Two screening instruments were required to identify all cases. Cognitive impairment was significantly associated with health literacy and worth further investigation.

22 February 2024 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
GCGeorgina Cornall
Georgina Cornall
EZEmma Zhao
Emma Zhao
TLTim Luckett
Tim Luckett
EEErtugrul Erciyas
Ertugrul Erciyas
DMDavid Monck
David Monck
YLYi-Ching Lee
Yi-Ching Lee
The ongoing COVID-19 pandemic has impacted health systems globally and affected managing many chronic conditions, including cancer. This study aimed to explore the perceptions of multi-disciplinary cancer care providers on how cancer pain management was affected by the COVID-19 pandemic. Participants were eligible if they were cancer care providers of any specialty and discipline from two tertiary hospitals in Australia. Data were collected using semi-structured interviews to explore cancer care providers’ perspectives on cancer pain management within COVID-19. Thematic analysis of interview transcripts used an integrated approach that started with inductive coding before coding deductively against a behaviour framework called the COM-B Model, which proposes that ‘capability’, ‘motivation’ and ‘opportunity’ are requisites for any behaviour. Twenty-three providers participated. Five themes were developed and interpreted from the analysis of data, namely: “Telehealth enables remote access to cancer pain management but also created a digital divide”, “Access to cancer pain management in the community is compromised due to the pandemic”, “COVID-19 negatively impacts hospital resource allocation”, “Patients were required to trade off cancer pain management against other health priorities” and “Hospital restrictions result in decreased social and psychological support for patients with cancer pain”. The landscape of cancer pain management in the Australian health system underwent substantial shifts during the COVID-19 pandemic, with lasting impacts. Cancer care providers perceived the pandemic to have significant adverse effects on pain management across multiple levels, with repercussions for patients experiencing cancer-related pain. A more adaptive health system model needs to be established in the future to accommodate vulnerable cancer patients.

26 December 2022 in Journal of Cardiopulmonary Rehabilitation and Prevention
Verified
Journal Article
Closed access
RGRobyn Gallagher
Robyn Gallagher
KBKimberley Bassett
Kimberley Bassett
EZEmma Mn Zhao
Emma Mn Zhao
ABAdrian Bauman
Adrian Bauman
GTGeoffrey Tofler
Geoffrey Tofler
SNSharon L. Naismith
Sharon L. Naismith

17 June 2022 in European Journal of Cardiovascular Nursing
Verified
Journal Article
Open access
RGRobyn Gallagher
Robyn Gallagher
MOMeng-Lu Ouyang
Meng-Lu Ouyang
GTGeoffrey Tofler
Geoffrey Tofler
BABauman Adrian
Bauman Adrian
EZEmma Zhao
Emma Zhao
SNSharon L Naismith
Sharon L Naismith
Aims: This study aimed to determine the sensitivity and specificity of the National Institute of Neurological Disorders and Stroke (NINDS) and the Canadian Stroke Network (CSN) brief (5 min) screen composed of three items of the Montreal Cognitive Assessment (MoCA), in acute coronary syndrome (ACS) patients during hospital admission, relative to the full MoCA and potential alternative combinations of other items.Methods and results: Participants were consecutively recruited during ACS admission and administered the MoCA before discharge. The three NINDS–CSN screen items were extracted, collated and compared to the full MoCA. Receiver operator characteristic (ROC) curves were created to determine the sensitivity, specificity, and appropriate cut-off scores of the screens. The mean age of the sample (n = 81) was 63.49 [standard deviation (SD) 10.85] years and 49.4% screened positive for cognitive impairment. The NINDS–CSN mean score was 9.22 (SD 2.09 of the potential range 0–12). Area under the ROC (AUC) indicated high accuracy levels for screening for cognitive impairment (AUC = 0.89, P < 0.01, 95% confidence interval 0.82, 0.96) with none of the alternative combination screens performing better on both sensitivity and specificity. A cut-off score of ≤10 on the NINDS–CSN protocol provided 83% sensitivity and 80% specificity for classifying cognitive impairment.Conclusion: The NINDS–CSN protocol presents an accurate, feasible screen for cognitive impairment in patients following ACS for use at the bedside and potentially also for telephone screens. Diagnostic accuracy should be confirmed using a neurocognitive battery.